Macro Dashboard
| Indicator | Level | 5-Day Change | Signal |
|---|---|---|---|
| KOSPI | 6,820.6 | −8.8% | Bear |
| KOSDAQ | 791.8 | −5.4% | Bear |
| USD/KRW | 1,479 | −1.8% (KRW stronger) | Constructive |
| VIX | 16.1 | +7.1% | Stable |
| US 10Y | 4.54% | +0.01pp | Flat |
| Brent | $84.4/bbl | +1.4% | Steady |
Regime verdict: KR Bear / US Neutral. The five-day KOSPI drawdown of 8.8% is running nearly 3.4 percentage points wider than KOSDAQ (-5.4%), pointing to concentrated stress in large-cap and derivatives-linked positions. Futures basis held elevated at +15.99 while exchange program selling reached ₩1.3 trillion on the day — a pattern consistent with a forced institutional unwind rather than a clean macro breakdown. KRW strength of 1.8% over five days is the lone constructive macro signal.
Market Wrap
July 16 was a high-velocity, broad risk-off session. The KOSPI closed down 6.1% and the KOSDAQ fell 4.45%. Sell sidecars triggered on both boards simultaneously — a rare signal of maximum intraday selling pressure. Foreign investors and institutions sold in tandem; retail buyers absorbed most of the supply.
The selloff’s epicenter was memory and large-cap semiconductors. SK Hynix (000660.KS) dropped 11.5% on the session, with combined foreign and institutional net selling reaching ₩23,282bn over five sessions — retail absorbed ₩21,858bn of that supply. Samsung Electronics (005930.KS) fell 8.8%, dragging the KOSPI disproportionately given its index weight. Program flows compounded the pressure: arbitrage programs sold ₩232.7bn and non-arbitrage programs sold ₩1,068.5bn. ETF net creation of +₩265.8bn provided some passive offset, but was dwarfed by the headline drain.
The narrative triggering the move: a memory peak-out thesis built around CXMT’s aggressive capacity expansion in China, data center power and environmental constraints, and fears of demand deceleration. The market de-rated before fundamental confirmation arrived.
What makes today’s data worth parsing carefully: TSMC (2330.TW) just posted 2Q26 results running 13% above consensus — net profit of NT$706.6bn vs. NT$623.7bn estimate, gross margin of 67.7%. That does not validate a thesis that AI semiconductor capex is rolling over. Korean memory stocks de-rated anyway, which suggests the market is pricing supply-side risk rather than a demand collapse. Whether that distinction holds will be visible in coming weeks as memory pricing data and NAND/DRAM spot checks roll in.
Three semiconductor equipment names — PSK (319660.KS), VM (089970.KQ), and TSI (131290.KQ) — maintained relative strength scores above 98.0 on today’s screen but showed sub-1x volume ratios. These are on the emerging watchlist, not actionable breakout candidates; market stabilization is required before entry conviction is reasonable.
Today’s Quality Re-Rating Candidates
The KR Meta Screener covered 97 tickers today. Three names cleared all five screener layers simultaneously — Quality Compounder, Smart Money Quality, Smart Money Earnings, Cycle Rerating, and PEAD — which is the framework’s highest intersection tier. Finding names where institutional and foreign flow is still constructive on a day the KOSPI falls 6% is precisely the signal worth logging.
Screener Intersection Summary
| Rank | Ticker | Name | Meta Score | Screeners Hit | Key Metrics |
|---|---|---|---|---|---|
| 1 | 278470.KS | APR | 89.4 | QC · SMQ · SME · PEAD · KMS | ROE 65.0%, OP YoY +198%, F+QI +₩33.9bn 5D |
| 2 | 161890.KS | Korea Kolmar | 76.1 | QC · SMQ · SME · CR · KMS | ROE 14.7%, OP YoY +24%, Margin +0.9pp |
| 3 | 096530.KQ | Seegene | 70.7 | QC · SMQ · SME · CR · KMS | ROE 4.8%, OP YoY +310%, Margin +11.3pp |
| 4 | 420770.KQ | Gigavis | 66.1 | QC · CR · Consensus↑ · KMS | ROE 7.3%, OP YoY +777%, Margin +29.9pp |
| 5 | 005935.KS | Samsung Elec. Pref | 51.0 | QC · CR · KMS | ROE 10.8%, OP YoY +33%, Margin +2.2pp |
| 6 | 089970.KQ | VM | 49.6 | QC · CR · KMS | ROE 14.7%, OP YoY +387%, Margin +29.3pp |
| 7 | 009150.KS | Samsung Electro-Mech. | 48.0 | QC · CR · KMS | ROE 7.4%, OP YoY +24%, 2 DART IR events |
| 8 | 000660.KS | SK Hynix | 43.0 | QC · CR · KMS | ROE 35.6%, OP YoY +101%, Margin +13.1pp |
| 9 | 319660.KS | PSK | 41.2 | QC · KMS | ROE 15.5%, OP YoY +6% |
| 10 | 402340.KS | SK Square | 33.3 | QC · KMS | ROE 31.9%, OP YoY +125%, 6 DART catalysts |
QC = Quality Compounder · SMQ = Smart Money Quality · SME = Smart Money Earnings · CR = Cycle Rerating · KMS = Kiwoom Market Surface · Consensus↑ = Consensus Up Revision
Top 3 in Focus
APR (278470.KS) — Score 89.4, 5 screeners APR is a Korean direct-to-consumer beauty brand operator — brands include Medicube and TFIT — with a growing DTC presence across Asia and the U.S. It clears all five screener layers: ROE of 65%, operating profit up 198% year-over-year, and five-day smart money net buying of +₩33.9bn while retail sold ₩35.8bn. Two DART filings hit today — a cash dividend declaration and a shareholder record date — which are concrete catalyst signals aligned with the quality-plus-earnings framework. Caution: short interest sits at 6.5%, and the qualitative institutional flow indicator is marginally negative, with the bulk of institutional buying concentrated in financial investment accounts rather than long-only. The question to verify next: whether the dividend catalyst pulls in fresh long-only commitment in coming sessions.
Korea Kolmar (161890.KS) — Score 76.1, 5 screeners Korea Kolmar is one of Korea’s top cosmetics ODM/OEM manufacturers, supplying both domestic conglomerates and global beauty groups. It clears the full quality-plus-rerating stack: Quality Compounder, Smart Money Quality, Smart Money Earnings, Cycle Rerating, and the Kiwoom market surface. Operating margin expanded 0.9pp and OP grew 23.6% YoY; the qualitative institutional flow signal is positive. An IR event was filed via DART on July 6. Caution: foreign broker net selling is flagged, and short interest is 7.4%. The next check is whether the IR event triggers consensus revisions in the forward estimate deck.
Seegene (096530.KQ) — Score 70.7, 5 screeners Seegene is Korea’s leading molecular diagnostics company, best known for its PCR multiplex testing platforms. ROE at 4.8% is modest, but the operating profit recovery — up 310% YoY with margin expansion of +11.3pp — suggests a business exiting a post-COVID trough and beginning to be re-priced by the market. Five-day smart money net buying is +₩5.7bn against retail selling of ₩5.0bn. Caution: short interest at 10.5%, bid-ask spread premium at +24%, and foreign broker activity is negative. The margin expansion is the load-bearing variable: if this is a one-quarter spike rather than a structural shift, the screener signal loses its weight quickly.
Screener key: Quality Compounder (ROE durability, earnings trajectory), Smart Money Quality (institutional/foreign 5-day net flow), Cycle Rerating (margin expansion catching a re-pricing), Smart Money Earnings (earnings improvement confirmation), PEAD (post-earnings drift). Meta scores are composite research-priority signals, not buy recommendations. Verify via DART official filings and live consensus data before drawing conclusions.